BML Investment Partners, L.P. 13D and 13G filings for Enliven Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-07 12:16 pm Sale | 2023-12-31 | 13G | ENLIVEN THERAPEUTICS INC ELVN | BML Investment Partners, L.P. | 50,000 0.100% | -3,287,774 (-98.50%) | Filing |